Written question asked by Norman Baker (Liberal Democrat) on Wednesday, 8 May 2002, in the House of Commons. It was due for an answer on Monday, 10 June 2002. It was answered by Hazel Blears (Labour) on Monday, 10 June 2002 on behalf of the Department of Health.

Dept of Health

Question: To ask the Secretary of State for Health, what steps he takes to ensure, in the testing of drugs for potential carcinogenicity, commercial companies do not select animal species and strains of species where the incidence of carcinogenicity is low. (Guidance in Library Dep 02/1171). - (Holding answer 14 May 2002).

Answer: Norman Baker: To ask the Secretary of State for Health what steps he takes to ensure, in the testing of drugs for potential carcinogenicity, commercial companies do not select animal species and strains of species where the incidence of carcinogenicity is low. [56017] Ms Blears: [holding answer 14 May 2002]: The rationale for selecting species to be used in the carcinogenicity studies is stated in the guidance documents produced as a result of the International Conference of Harmonisation.

Secondary information

Type: Written question
Reference: 56017; 386 c1089W
Session: 2001-02
Subjects: Animals Cancer Animal experiments Drugs Research Testing Carcinogens
Link: View this Written question on www.publications.parliament.uk